NRC Health Earnings Call Transcripts
Fiscal Year 2026
-
The meeting confirmed quorum and proceeded with the election of seven directors, ratification of KPMG as auditor, approval of executive compensation, and several amendments to the Certificate of Incorporation, all of which passed by shareholder vote.
-
A leading healthcare experience management provider reported strong recurring revenue, robust margins, and a $5B market opportunity. Recent growth is driven by product innovation, AI, and a revamped salesforce, with a major new client set to generate revenue starting July.
-
Research shows that high-quality rounding significantly boosts patient loyalty, primarily by enhancing trust and communication. Technology like ambient listening further improves interaction quality by reducing distractions and supporting leaders in capturing meaningful insights.
-
Q1 2026 delivered record TRCV, strong sales growth, and a landmark multi-year deal, driving revenue up 4% year-over-year and boosting profitability. Near-term margins will be flat due to implementation costs, but long-term EBITDA margin is expected to return to the 30s.
-
Conflicting patient experience data can be resolved by recognizing the strong relationship between NPS and HCAHPS, focusing on long-term trends, and using timely, representative feedback. Prioritizing key drivers like nurse communication and care coordination, along with supportive leadership and targeted demographic analysis, accelerates improvement and financial outcomes.
Fiscal Year 2025
-
Q4 2025 saw revenue of $35.2M and Adjusted EBITDA of $8.7M, with TRCV up 8% year-over-year. New sales surged 86%, customer retention hit a seven-year high, and product innovation—including AI—remains a strategic focus for 2026.
-
Revenue grew to $34.6 million in Q3 2025, with adjusted EBITDA up 11% year-over-year and TRCV rising 8%. Strong customer expansion, improved retention, and a 33% dividend increase highlight robust performance and confidence in future growth.
-
Sequential TRCV growth and a strong Adjusted EBITDA margin highlight operational momentum, with the new CEO focused on sustainable growth and strategic planning. Share repurchases and dividends continue, while the company leverages its unique healthcare expertise and customer success model.
Fiscal Year 2024
-
Healthcare IT faces challenges like staff burnout, equity gaps, and low institutional trust, but opportunities exist to use AI and digital tools to reduce administrative burdens and improve access. Success depends on transparency, clinical involvement, and keeping patient well-being central.
-
AI is transforming healthcare experience management by reducing administrative burdens, enhancing listening and personalization, and supporting staff through tools like Huey. Huey stands out for its healthcare-specific design, ethical focus, and privacy-first approach, with ongoing development driven by real-world needs.
-
Major CAHPS Hospice and HCAHPS survey updates take effect in 2025, including new question sets, extended data collection periods, and revised methodologies. Public reporting and Value-Based Purchasing Program measures will shift, with new sub-measures phased in by 2026 and 2030. Key compliance deadlines and resource access details were also provided.